Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hanmi Pharm Ind Co LtdfiledCriticalHanmi Pharm Ind Co Ltd
Publication of ECSP11011252ApublicationCriticalpatent/ECSP11011252A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La presente invención se relaciona con una composición farmacéutica sólida, para prevenir o tratar desórdenes cardiovasculares, que contiene amlodipina o una sal de la misma farmacéuticamente aceptable y, losartán o una sal del mismo farmacéuticamente aceptable, donde dicha composición muestra altas proporciones de disolución de la amlopidina y del losartán, aún bajo una condición de pH bajo y además una estabilidad de almacenamiento mejorada.The present invention relates to a solid pharmaceutical composition, for preventing or treating cardiovascular disorders, which contains amlodipine or a pharmaceutically acceptable salt thereof, and losartan or a pharmaceutically acceptable salt thereof, wherein said composition shows high dissolution rates of the amlopidine and losartan, even under a low pH condition and also improved storage stability.
ECSP110112522009-01-232011-08-09
SOLID PHARMACEUTICAL COMPOSITION CONTAINING AMLOPIDINE AND LOSARTAN, AS WELL AS THE PROCESS TO PRODUCE THE SAME.
ECSP11011252A
(en)
Compounds derived from n- (1-4- (1h-pyrazol-5-yl) phthalazine-1-yl) piperidine-4-yl) benzamide; pharmaceutical composition that contains them, useful as antagonist of the hedgehog trajectory, in the treatment of cancer.
Composition for treating or preventing diseases caused by vascular permeability, containing imatinib or pharmaceutically acceptable salt thereof as active ingredient.